GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Helix BioMedix HXBM · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.29

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Helix BioMedix — daily HXBM Delayed
Market value
$544,824
Last close × shares
Volume
100
Shares, 9 Nov 2026

About Helix BioMedix

Its shares trade under the ticker HXBM. It has been listed since 25 July 2000. In the fiscal year to 31 December 2025, it reported revenue of $807,193 and a net loss of $551,512. At that date it held total assets of $1.7m and shareholders' equity of $1.5m.

Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company is headquartered in Bothell, Washington. The company went IPO on 2000-07-25. The Company’s lead drug development candidate, HB4208, is a deoxyribonucleic damage response enzyme for topical treatment of the rare genetic disorder (orphan disease) Xeroderma Pigmentosum (XP). Its intellectual property portfolio offers multiple pathways for commercialization in this area ranging from Rx dermatology to aesthetic dermatology and personal care. The company is developing new treatment options for dermatologic conditions which offer the therapeutic effectiveness and safety benefits of its advanced bioactive small molecule technology. The company is transforming the treatment of skin conditions by addressing unmet needs in elegant, life-enhancing topical formulations. Its research and development consist of a proprietary library of bioactive peptides based on the body’s innate immunity.

Figures and description from our data supplier, not checked against the company's own report.

More about Helix BioMedix →

Latest on Helix BioMedix

Our reporting

We have not reported on Helix BioMedix yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Helix BioMedix's ticker?

Helix BioMedix trades as HXBM on its US listing, under ISIN US4232875074.

What was Helix BioMedix's last closing price?

3.29 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.